Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron
| Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
| Descrizione fisica | 1 online resource (526 p.) |
| Disciplina |
616.1/24
616.124 |
| Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
| Soggetto topico | Heart - Hypertrophy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
| Record Nr. | UNINA-9910143294503321 |
| Malden, Mass., : Blackwell Futura, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron
| Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
| Descrizione fisica | 1 online resource (526 p.) |
| Disciplina |
616.1/24
616.124 |
| Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
| Soggetto topico | Heart - Hypertrophy |
| ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
| Record Nr. | UNISA-996214611603316 |
| Malden, Mass., : Blackwell Futura, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron
| Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
| Descrizione fisica | 1 online resource (526 p.) |
| Disciplina |
616.1/24
616.124 |
| Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
| Soggetto topico | Heart - Hypertrophy |
| ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
| Record Nr. | UNINA-9910830565003321 |
| Malden, Mass., : Blackwell Futura, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Markers in cardiology [[electronic resource] ] : a case-oriented approach / / edited by Jesse E. Adams
| Markers in cardiology [[electronic resource] ] : a case-oriented approach / / edited by Jesse E. Adams |
| Pubbl/distr/stampa | Oxford, : Blackwell, 2007 |
| Descrizione fisica | 1 online resource (274 p.) |
| Disciplina |
616.1/24
616.12 |
| Altri autori (Persone) | AdamsJesse E |
| Soggetto topico |
Heart - Diseases - Diagnosis
Biochemical markers |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-06925-6
9786611069254 0-470-69198-0 0-470-76575-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Markers in Cardiology : A CASE-ORIENTED APPROACH; Contents; Contributors; Preface; Part 1 Cardiac troponins; 1 Basics of cardiac troponin: practical aspects of assays, potential analytical confounders, and clinical interpretation; 2 Diagnostic use of cardiac troponins in ST-segment elevation myocardial infarction; 3 Therapeutic implications of cardiac troponins in ST-segment elevation and non-ST-segment elevation myocardial infarction; 4 Ischemic heart disease in the absence of overt coronary artery disease; 5 So you think you have a ""false positive'' troponin?
6 Use of cardiac troponin in patients in non-ischemic pathologies and exposure to environmental toxins7 Cardiac troponins in patients with congestive heart failure; 8 Troponins and the critically Ill patient; 9 Cardiac troponins and renal failure; 10 Cardiac biomarkers: detection of in-hospital myocardial reinfarction; Part 2 Natriuretic peptides; 11 The future: interpreting new guidelines for myocardial infarction; 12 Basics of natriuretic peptides: practical aspects of assays, potential analytical confounders, and clinical interpretation,; 13 Natriruetic peptides in clinical practice 14 Outpatient evaluation for cardiovascular diseases using natriuretic peptide testing15 Natriuretic peptides in patients with renal failure; 16 Congestive heart failure: treatment implications of natriuretic peptides; 17 Utilizing multimarker strategies in patients who present with congestive heart failure; Part 3 Contemporary markers of risk; 18 Clinical integration of C-reactive protein for primary and secondary risk factor stratification; 19 Lipoprotein subfraction analysis using nuclear magnetic resonance spectroscopy; Index |
| Record Nr. | UNINA-9910145278003321 |
| Oxford, : Blackwell, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Markers in cardiology [[electronic resource] ] : a case-oriented approach / / edited by Jesse E. Adams
| Markers in cardiology [[electronic resource] ] : a case-oriented approach / / edited by Jesse E. Adams |
| Pubbl/distr/stampa | Oxford, : Blackwell, 2007 |
| Descrizione fisica | 1 online resource (274 p.) |
| Disciplina |
616.1/24
616.12 |
| Altri autori (Persone) | AdamsJesse E |
| Soggetto topico |
Heart - Diseases - Diagnosis
Biochemical markers |
| ISBN |
1-281-06925-6
9786611069254 0-470-69198-0 0-470-76575-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Markers in Cardiology : A CASE-ORIENTED APPROACH; Contents; Contributors; Preface; Part 1 Cardiac troponins; 1 Basics of cardiac troponin: practical aspects of assays, potential analytical confounders, and clinical interpretation; 2 Diagnostic use of cardiac troponins in ST-segment elevation myocardial infarction; 3 Therapeutic implications of cardiac troponins in ST-segment elevation and non-ST-segment elevation myocardial infarction; 4 Ischemic heart disease in the absence of overt coronary artery disease; 5 So you think you have a ""false positive'' troponin?
6 Use of cardiac troponin in patients in non-ischemic pathologies and exposure to environmental toxins7 Cardiac troponins in patients with congestive heart failure; 8 Troponins and the critically Ill patient; 9 Cardiac troponins and renal failure; 10 Cardiac biomarkers: detection of in-hospital myocardial reinfarction; Part 2 Natriuretic peptides; 11 The future: interpreting new guidelines for myocardial infarction; 12 Basics of natriuretic peptides: practical aspects of assays, potential analytical confounders, and clinical interpretation,; 13 Natriruetic peptides in clinical practice 14 Outpatient evaluation for cardiovascular diseases using natriuretic peptide testing15 Natriuretic peptides in patients with renal failure; 16 Congestive heart failure: treatment implications of natriuretic peptides; 17 Utilizing multimarker strategies in patients who present with congestive heart failure; Part 3 Contemporary markers of risk; 18 Clinical integration of C-reactive protein for primary and secondary risk factor stratification; 19 Lipoprotein subfraction analysis using nuclear magnetic resonance spectroscopy; Index |
| Record Nr. | UNINA-9910830347603321 |
| Oxford, : Blackwell, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Markers in cardiology : a case-oriented approach / / edited by Jesse E. Adams
| Markers in cardiology : a case-oriented approach / / edited by Jesse E. Adams |
| Pubbl/distr/stampa | Oxford, : Blackwell, 2007 |
| Descrizione fisica | 1 online resource (274 p.) |
| Disciplina |
616.1/24
616.12 |
| Altri autori (Persone) | AdamsJesse E |
| Soggetto topico |
Heart - Diseases - Diagnosis
Biochemical markers |
| ISBN |
1-281-06925-6
9786611069254 0-470-69198-0 0-470-76575-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Markers in Cardiology : A CASE-ORIENTED APPROACH; Contents; Contributors; Preface; Part 1 Cardiac troponins; 1 Basics of cardiac troponin: practical aspects of assays, potential analytical confounders, and clinical interpretation; 2 Diagnostic use of cardiac troponins in ST-segment elevation myocardial infarction; 3 Therapeutic implications of cardiac troponins in ST-segment elevation and non-ST-segment elevation myocardial infarction; 4 Ischemic heart disease in the absence of overt coronary artery disease; 5 So you think you have a ""false positive'' troponin?
6 Use of cardiac troponin in patients in non-ischemic pathologies and exposure to environmental toxins7 Cardiac troponins in patients with congestive heart failure; 8 Troponins and the critically Ill patient; 9 Cardiac troponins and renal failure; 10 Cardiac biomarkers: detection of in-hospital myocardial reinfarction; Part 2 Natriuretic peptides; 11 The future: interpreting new guidelines for myocardial infarction; 12 Basics of natriuretic peptides: practical aspects of assays, potential analytical confounders, and clinical interpretation,; 13 Natriruetic peptides in clinical practice 14 Outpatient evaluation for cardiovascular diseases using natriuretic peptide testing15 Natriuretic peptides in patients with renal failure; 16 Congestive heart failure: treatment implications of natriuretic peptides; 17 Utilizing multimarker strategies in patients who present with congestive heart failure; Part 3 Contemporary markers of risk; 18 Clinical integration of C-reactive protein for primary and secondary risk factor stratification; 19 Lipoprotein subfraction analysis using nuclear magnetic resonance spectroscopy; Index |
| Record Nr. | UNISA-996213962703316 |
| Oxford, : Blackwell, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Mechanical reperfusion for STEMI : from randomized trials to clinical practice / / edited by Giuseppe De Luca, Alexandra Lansky
| Mechanical reperfusion for STEMI : from randomized trials to clinical practice / / edited by Giuseppe De Luca, Alexandra Lansky |
| Pubbl/distr/stampa | New York : , : Informa Healthcare, , 2010 |
| Descrizione fisica | 1 online resource (310 p.) |
| Disciplina | 616.1/24 |
| Altri autori (Persone) |
De LucaGiuseppe <1974->
LanskyAlexandra |
| Soggetto topico |
Myocardial infarction - Treatment
Myocardial reperfusion |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-429-06600-7
1-282-56095-6 9786612560958 1-84184-746-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Foreword; Preface; Contents; Chapter 1. Primary Angioplasty Vs. Fibrinolysis: An Overview of Randomized Trials and Registry Data; Chapter 2. Which Patients Should Be Transferred for Primary PCI?; Chapter 3. Pharmacological Facilitation in Primary Angioplasty: Myth or Reality? ; Chapter 4. How to Organize Hetworks for Invasive Treatment of STEMI: Krakow Experience; Chapter 4a. How to Organize Networks for Invasive Treatment of STEMI: Krakow Experience; Chapter 4b. How to Organize Networks for INvasive Treatment of STEMI: THe Zwolle Experience
Chapter 4c. How to Organize Networks for Invasive Treatment of STEMI: Link ̈oping ExperienceChapter 4d. How to Organize Networks for Invasive Treatment of STEMI: Experience in the United States; Chapter 4e. How to Organize Networks for Invasive Treatment of STEMI: Experience in Asia; Chapter 5: Failed Thrombolysis: Rescue Angioplasty or Conservative Therapy?; Chapter6. Primary PCI in Cardiogenic Shock and Out-of-Hospital Cardiac Arrest; Chapter 7. Oral Antiplatelet Therapy; Chapter 8. Glycoprotein IIb/IIIa Inhibitors; Chapter 9. Anticoagulation Therapy; Chapter 10. Balloon Angioplasty or BMS? Chapter 11. Drug-Eluting Stent: Weighing Costs and BenefitsChapter 12. Mechanical Prevention of Distal Embolization; Chapter 13. Distal Protection Devices: Tips and Tricks; Chapter 14. Thrombectomy Devices: Tips and Tricks; Chapter 15. Proximal Devices: Tips and Tricks; Chapter 16. Hemodynamic Support in High-Risk Patients; Chapter 17. Limitation of Infarct Size: Ajunctive Mechanical Devices; Chapter 18. Transradial Access for Primary PCI: Advantages beyond any Doubt; Chapter 19. Intravascular Imaging: IVUS, OCT, and Angioscopy Chapter 20. Redefining the Success of Mechanical Reperfusion: ST-Segment ResolutionChapter 21. Redefining the Success of Mechanical Reperfusion: TIMI Flow and Myocardial Blush; Chapter 22. Redifining the Success of Mechanical Reperfusion: Doppler Flow-Wire; Chapter 23. Redifining the Success of Mechanical Reperfusion: Cardiac MRI; Chapter 24. Redefining the Success of Mechanical Reperfusion: Contrast Echocardiography; Chapter 25. Redifining the Success of Mechanical Reperfusion Chapter 26. Bleeding Complications in Patients Undergowing Percutaneous Coronary Intervention: Prognostic Implications and PreventionChapter 27. Contrast-Induced Nephropathy in Patients Undergoing Primary Angioplasty: Prognostic Implications, Prevention, and Management; Chapter 28. Myocardial Regeneration: Cell-Therapy After Reperfusion in Patients with ST-Elevation Myocardial Infarction; Chapter 29. Early Discharge After Primary PCI; Chapter 30. ACC/AHA and ESC Guidelines; Index; Back Cover |
| Record Nr. | UNINA-9910456318503321 |
| New York : , : Informa Healthcare, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Mechanical reperfusion for STEMI : from randomized trials to clinical practice / / edited by Giuseppe De Luca, Alexandra Lansky
| Mechanical reperfusion for STEMI : from randomized trials to clinical practice / / edited by Giuseppe De Luca, Alexandra Lansky |
| Pubbl/distr/stampa | New York : , : Informa Healthcare, , 2010 |
| Descrizione fisica | 1 online resource (310 p.) |
| Disciplina | 616.1/24 |
| Altri autori (Persone) |
De LucaGiuseppe <1974->
LanskyAlexandra |
| Soggetto topico |
Myocardial infarction - Treatment
Myocardial reperfusion |
| ISBN |
0-429-06600-7
1-282-56095-6 9786612560958 1-84184-746-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Foreword; Preface; Contents; Chapter 1. Primary Angioplasty Vs. Fibrinolysis: An Overview of Randomized Trials and Registry Data; Chapter 2. Which Patients Should Be Transferred for Primary PCI?; Chapter 3. Pharmacological Facilitation in Primary Angioplasty: Myth or Reality? ; Chapter 4. How to Organize Hetworks for Invasive Treatment of STEMI: Krakow Experience; Chapter 4a. How to Organize Networks for Invasive Treatment of STEMI: Krakow Experience; Chapter 4b. How to Organize Networks for INvasive Treatment of STEMI: THe Zwolle Experience
Chapter 4c. How to Organize Networks for Invasive Treatment of STEMI: Link ̈oping ExperienceChapter 4d. How to Organize Networks for Invasive Treatment of STEMI: Experience in the United States; Chapter 4e. How to Organize Networks for Invasive Treatment of STEMI: Experience in Asia; Chapter 5: Failed Thrombolysis: Rescue Angioplasty or Conservative Therapy?; Chapter6. Primary PCI in Cardiogenic Shock and Out-of-Hospital Cardiac Arrest; Chapter 7. Oral Antiplatelet Therapy; Chapter 8. Glycoprotein IIb/IIIa Inhibitors; Chapter 9. Anticoagulation Therapy; Chapter 10. Balloon Angioplasty or BMS? Chapter 11. Drug-Eluting Stent: Weighing Costs and BenefitsChapter 12. Mechanical Prevention of Distal Embolization; Chapter 13. Distal Protection Devices: Tips and Tricks; Chapter 14. Thrombectomy Devices: Tips and Tricks; Chapter 15. Proximal Devices: Tips and Tricks; Chapter 16. Hemodynamic Support in High-Risk Patients; Chapter 17. Limitation of Infarct Size: Ajunctive Mechanical Devices; Chapter 18. Transradial Access for Primary PCI: Advantages beyond any Doubt; Chapter 19. Intravascular Imaging: IVUS, OCT, and Angioscopy Chapter 20. Redefining the Success of Mechanical Reperfusion: ST-Segment ResolutionChapter 21. Redefining the Success of Mechanical Reperfusion: TIMI Flow and Myocardial Blush; Chapter 22. Redifining the Success of Mechanical Reperfusion: Doppler Flow-Wire; Chapter 23. Redifining the Success of Mechanical Reperfusion: Cardiac MRI; Chapter 24. Redefining the Success of Mechanical Reperfusion: Contrast Echocardiography; Chapter 25. Redifining the Success of Mechanical Reperfusion Chapter 26. Bleeding Complications in Patients Undergowing Percutaneous Coronary Intervention: Prognostic Implications and PreventionChapter 27. Contrast-Induced Nephropathy in Patients Undergoing Primary Angioplasty: Prognostic Implications, Prevention, and Management; Chapter 28. Myocardial Regeneration: Cell-Therapy After Reperfusion in Patients with ST-Elevation Myocardial Infarction; Chapter 29. Early Discharge After Primary PCI; Chapter 30. ACC/AHA and ESC Guidelines; Index; Back Cover |
| Record Nr. | UNINA-9910781032903321 |
| New York : , : Informa Healthcare, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Mechanical reperfusion for STEMI : from randomized trials to clinical practice / / edited by Giuseppe De Luca, Alexandra Lansky
| Mechanical reperfusion for STEMI : from randomized trials to clinical practice / / edited by Giuseppe De Luca, Alexandra Lansky |
| Pubbl/distr/stampa | New York : , : Informa Healthcare, , 2010 |
| Descrizione fisica | 1 online resource (310 p.) |
| Disciplina | 616.1/24 |
| Altri autori (Persone) |
De LucaGiuseppe <1974->
LanskyAlexandra |
| Soggetto topico |
Myocardial infarction - Treatment
Myocardial reperfusion |
| ISBN |
0-429-06600-7
1-282-56095-6 9786612560958 1-84184-746-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Foreword; Preface; Contents; Chapter 1. Primary Angioplasty Vs. Fibrinolysis: An Overview of Randomized Trials and Registry Data; Chapter 2. Which Patients Should Be Transferred for Primary PCI?; Chapter 3. Pharmacological Facilitation in Primary Angioplasty: Myth or Reality? ; Chapter 4. How to Organize Hetworks for Invasive Treatment of STEMI: Krakow Experience; Chapter 4a. How to Organize Networks for Invasive Treatment of STEMI: Krakow Experience; Chapter 4b. How to Organize Networks for INvasive Treatment of STEMI: THe Zwolle Experience
Chapter 4c. How to Organize Networks for Invasive Treatment of STEMI: Link ̈oping ExperienceChapter 4d. How to Organize Networks for Invasive Treatment of STEMI: Experience in the United States; Chapter 4e. How to Organize Networks for Invasive Treatment of STEMI: Experience in Asia; Chapter 5: Failed Thrombolysis: Rescue Angioplasty or Conservative Therapy?; Chapter6. Primary PCI in Cardiogenic Shock and Out-of-Hospital Cardiac Arrest; Chapter 7. Oral Antiplatelet Therapy; Chapter 8. Glycoprotein IIb/IIIa Inhibitors; Chapter 9. Anticoagulation Therapy; Chapter 10. Balloon Angioplasty or BMS? Chapter 11. Drug-Eluting Stent: Weighing Costs and BenefitsChapter 12. Mechanical Prevention of Distal Embolization; Chapter 13. Distal Protection Devices: Tips and Tricks; Chapter 14. Thrombectomy Devices: Tips and Tricks; Chapter 15. Proximal Devices: Tips and Tricks; Chapter 16. Hemodynamic Support in High-Risk Patients; Chapter 17. Limitation of Infarct Size: Ajunctive Mechanical Devices; Chapter 18. Transradial Access for Primary PCI: Advantages beyond any Doubt; Chapter 19. Intravascular Imaging: IVUS, OCT, and Angioscopy Chapter 20. Redefining the Success of Mechanical Reperfusion: ST-Segment ResolutionChapter 21. Redefining the Success of Mechanical Reperfusion: TIMI Flow and Myocardial Blush; Chapter 22. Redifining the Success of Mechanical Reperfusion: Doppler Flow-Wire; Chapter 23. Redifining the Success of Mechanical Reperfusion: Cardiac MRI; Chapter 24. Redefining the Success of Mechanical Reperfusion: Contrast Echocardiography; Chapter 25. Redifining the Success of Mechanical Reperfusion Chapter 26. Bleeding Complications in Patients Undergowing Percutaneous Coronary Intervention: Prognostic Implications and PreventionChapter 27. Contrast-Induced Nephropathy in Patients Undergoing Primary Angioplasty: Prognostic Implications, Prevention, and Management; Chapter 28. Myocardial Regeneration: Cell-Therapy After Reperfusion in Patients with ST-Elevation Myocardial Infarction; Chapter 29. Early Discharge After Primary PCI; Chapter 30. ACC/AHA and ESC Guidelines; Index; Back Cover |
| Record Nr. | UNINA-9910823425503321 |
| New York : , : Informa Healthcare, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Variants of ventricular preexcitation [[electronic resource] ] : recognition and treatment / / Eduardo Back Sternick, Hein J. Wellens
| Variants of ventricular preexcitation [[electronic resource] ] : recognition and treatment / / Eduardo Back Sternick, Hein J. Wellens |
| Autore | Sternick Eduardo Back |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, 2006 |
| Descrizione fisica | 1 online resource (166 p.) |
| Disciplina | 616.1/24 |
| Altri autori (Persone) | WellensH. J. J |
| Soggetto topico |
Wolff-Parkinson-White syndrome
Excitation (Physiology) |
| ISBN |
1-281-32044-7
9786611320447 0-470-76456-2 0-470-99499-1 0-470-99498-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Variants of Ventricular Preexcitation: RECOGNITION AND TREATMENT; Contents; Foreword; Acknowledgements; 1 Historical notes and classification of the variants of ventricular preexcitation; 2 The anatomy of decrementally conducting fibers; 3 Atriofascicular pathways and decrementally conducting long atrioventricular pathways; 4 The short AV decrementally conducting fibers; 5 Nodoventricular and Nodofascicular fibers; 6 Fasciculoventricular fibers; 7 Conduction disturbances in accessory pathways; 8 Automaticity in decrementally conducting fibers
9 Differential diagnosis of left bundle branch block-shaped tachycardiasIndex; Colour Plates |
| Record Nr. | UNINA-9910143945803321 |
Sternick Eduardo Back
|
||
| Malden, Mass., : Blackwell Futura, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
